About the Journal
Focus and Scope
Brawijaya Journal of Urology conveys regularly the essential results of urological research and their practical and clinical relevance to a broad audience of urologists in research and clinical practice. In order to guarantee a balanced program, articles are published to reflect the developments in all fields of urology on an internationally advanced level. All manuscripts are subject to peer review and are judged on the basis of their contribution of original data and ideas or interpretation.
Subject area this journal:
- Cancer and stem cells
- Cell and molecular biology
- Female and neurourology
- Internal medicine
- Kidney transplant
- Paediatric Urology
- Trauma and reconstruction urethra
Brawijaya Journal of Urology publishes peer-reviewed articles in basic medical research, clinical research, community research, case report/series, review article, and brief communication. All of the manuscripts must be submitted through online submission and go through peer review process as mentioned in another section. This journal also has other sections such as, editorial, correspondence, and commentary which are not peer-reviewed.
The submitted manuscript will be checked by an editor for its suitability with Brawijaya Journal of Urology’s focus and scope and for major methodological flaws within two weeks. Staff will work with the author to fulfill all the requirements within two weeks. Every submitted manuscript which passes this step will then be checked for plagiarism by Similarity Check. The manuscript needs to be re-worked if indicated for minor plagiarism and will be rejected if indicated for major plagiarism. Then, an editor-in-charge and an editorial assistant will be assigned for the manuscript. In this stage, the manuscript will be assessed based on novelty and adherence to reporting guidelines. Subsequently, the manuscript will go through peer-review process. The revisions may be required and will be re-evaluated by the editor-in-charge after the authors providing sufficient responses. The manuscript will be passed to the editor-in-chief for any further revision and ultimately will take an editorial decision. The accepted manuscript will be sent to copyediting stage for correction of grammar and spelling errors, standardizing the journal in-house style, improving table, figure, and writing quality. The incomplete revision of this stage will result in pending scheduled publication. Then, the manuscript will enter production stage for typesetting. A pdf file is sent to the author for review and there should be no more scientific revision. A failure to comply will result in a delay of the publication since it needs editor confirmation for the changes. It will be scheduled for publication after the payment has been received. The final approval is needed from the corresponding author before it is published. The manuscript submitted by one of the editorial team of the Brawijaya Journal of Urology will be processed by other editorial board members who do not have any conflict of interest with the manuscript and follow the same editorial process.
Peer Review Process
All submitted manuscripts (except editorial, commentary, and correspondence) in Brawijaya Journal of Urology undergo double-blind peer review by at least two reviewers. All manuscripts are sent to the reviewers anonymously. Reviewers’ comments are also sent anonymously to the corresponding author to take the necessary actions and responses. All the reviewers are subjected to submit their evaluation not more than six weeks. Brawijaya Journal of Urology staff ensures that the referee reports are complete. On some occasions, the review process needs more time to seek the appropriate reviewers.
Authors retain copyright and grant Faculty of Medicine Universitas Brawijaya, Department Urology. Authors are permitted to copy and redistribute the journal’s published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Brawijaya Journal of Urology.
The commercial use of any article is not permitted without our prior written consent and payment of the appropriate fees, even if you are the author or the employer, funder or affiliate organization of the author of the article. For the purposes of these terms, “commercial use” means use in any manner that is primarily intended for or directed toward commercial advantage or monetary compensation, including but not limited to provision or distribution of any article or part of any article (including any abstract, figures or tables) in any format: to support marketing activities; in response to medical information requests; to support activities at a conference, exhibition or trade show; as resource material on a company or product-specific website.
The Brawijaya Journal of Urology was founded in 2020. The mission of our journal is to provide biomedical scientists, clinical, and public health researchers as well as other health care professionals with the media to publish their research works.
This journal is published twice a year, in January and July.
Open Access Policy
Brawijaya Journal of Urology is an open access journal which provides immediate, worldwide, barrier-free access to the full text of all published articles without charge readers or their institutions for access. Readers have right to read, download, copy, distribute, print, search, or link to the full texts of all articles in the Brawijaya Journal of Urology.
Editorial materials will not be influenced by advertisement. Readers can criticize the advertisement by sending it to the office. Advertisement will appear in the print or online version depending on request. For all inquiries, contact the Brawijaya Journal of Urology editorial office at Department of Urology Malang, Jl. Jaksa Agung Suprapto 2 Malang Telp/Fax: +62 341 333030.
The subscription fee is free for foreign and Indonesian authors. The subscribers need to fill the forms. For further questions contact us at firstname.lastname@example.org.
Brawijaya Journal of Urology accepts revenues from various sources to ensure the quality of the peer-review process and published articles. The sources of income include publication fees, advertisement, events (training), subscription fees, and support from Department of Urology Malang. None of the editorial decision is influenced by the revenue itself. The waived publication fee is covered by the Brawijaya Journal of Urology to help researchers with limited resources. The waiving cost does not influence the editorial decision.
Updated - May 2020